Wearable technology innovation in healthcare and medical devices

13
How consumer wearable technology is driving innovation in healthcare and medical devices IDTechEx Sensors USA November 17 th , 2016

Transcript of Wearable technology innovation in healthcare and medical devices

Page 1: Wearable technology innovation in healthcare and medical devices

How consumer wearable technology is driving innovation in healthcare and medical devices

IDTechEx Sensors USANovember 17th, 2016

Page 2: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

Outline

• Historical timeline of the wearables market

• The effect of disruptive advances to wearable sensors

• Current B2B market pull in health/medical wearables

• Challenges and optimism in merging consumer tech with medical use cases

• Summary – key take-ways

Page 3: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

Heart RateChest Straps

Activity Trackers

GPS Armband

Calorimetry

Wireless vital signs monitors

Integrated solutions/ smart-devices

1980 2000 2006-09 20122010

Mobile Tracking Apps

2013

Wrist/arm activity trackers

2014 -16

Compelling use cases

2017-18 2019-20

Health/medicalwearables

Wearables are trending towards familiar form-factors, and more compelling user cases (including health)

Page 4: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. IncVALENCELL CONFIDENTIAL INFORMATION

Disease management

Guided fitness training

Prevention

Sleep quality

Diet management

Stress Management

Health diagnostics

Wearable optical sensor systems are now demonstrating performance levels suitable for medical use cases

Page 5: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

Atrial fibrillation identification has been demonstrated using optical sensor systems embedded in audio earbuds & wristbands

VALENCELL CONFIDENTIAL INFORMATION, PATENTS GRANTED & PENDING

Time (Sec)0 50 100 150 200 250 300 350 400

Cou

nts

4500

4600

4700

4800

4900

5000

5100

5200PK20160621 154043 (ScSa) CB4 JOBS JOBS15.18.7

Time (Sec)0 50 100 150 200 250 300 350 400

RR

I (m

Sec)

800

900

1000

1100

1200

1300

1400

1500RRI

DevicePolar

RRI (mSec)900 1000 1100 1200 1300 1400

Cou

nts

0

2

4

6

8

10

12

14

16RRI Distribution

DevicePolar

RRIn (ms)600 800 1000 1200 1400

RR

I n+1 (m

s)

500

600

700

800

900

1000

1100

1200

1300

1400Poincare Plot

DevicePolar

Frequency (Hz)0 0.1 0.2 0.3 0.4

PSD

(s2 /H

z)

0

0.2

0.4

0.6

0.8

1

Lomb-Scargle Periodogram

DevicePolar

Valencell OHRMECG

Time (Sec)0 50 100 150 200 250 300 350 400

Cou

nts

5100

5150

5200

5250

5300

5350

5400

5450PK20160621 141736 (DoSm) CB4 KONA KONA9.2.3.M

Time (Sec)0 50 100 150 200 250 300 350 400

RR

I (m

Sec)

500

600

700

800

900

1000

1100RRI

DevicePolar

RRI (mSec)700 750 800 850 900

Cou

nts

0

10

20

30

40

50

RRI Distribution

DevicePolar

RRIn (ms)600 800 1000 1200 1400

RR

I n+1 (m

s)

500

600

700

800

900

1000

1100

1200

1300

1400Poincare Plot

DevicePolar

Frequency (Hz)0 0.1 0.2 0.3 0.4

PSD

(s2 /H

z)

0

0.05

0.1

0.15

0.2

0.25

0.3

Lomb-Scargle Periodogram

DevicePolar

Valencell OHRMECG

Normal Poincaré Plot Atrial Fibrillation Detected

Page 6: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

70 80 90 100 110 120 130 140 150 160 170-40

-30

-20

-10

0

10

20

30

Bland-Altman SBP

Mean SBP

Diff

SB

P

40 50 60 70 80 90 100-30

-25

-20

-15

-10

-5

0

5

10

15

20

Bland-Altman DBP

Mean DBPDi

ff D

BP

70 80 90 100 110 120 130 140 150 160 17070

80

90

100

110

120

130

140

150

160

170

R² = 0.710605341205325

SBP Regression Analysis

Model SBP

Ben

chm

ark

SBP

40 50 60 70 80 90 10040

50

60

70

80

90

100

R² = 0.545290808208612

DBP Regression Analysis

Model DBP

Benc

hmar

k DB

P

Error = -0.1 ± 9 mmHg (mean ± SD) Error = 0.0 ± 8 mmHg (mean ± SD)

Systolic & diastolic blood pressure tracking has been demonstrated via finger & earbud-based optical sensor systems

VALENCELL CONFIDENTIAL INFORMATION, PATENTS GRANTED & PENDING

Page 7: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

Commercial innovation in consumer biometric wearables is beginning to outpace that of medical monitoring technology

$10,000 clinical biometric data collection system

$500 consumer biometric data collection system

Page 8: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. IncVALENCELL CONFIDENTIAL INFORMATION

Market pull for wearable biometric sensors in 5 key categories

Personal Health

(Prevention)

Clinical Research

Disease Management

Disease Diagnosis Therapeutics

Description General fitness and wellness sensors having prevention-based UX

Sensors for measuring biometrics and activity used in clinical research

Sensors for chronic disease management, such as COPD, asthma, diabetes, and cardiovascular disease

Sensors for screening or diagnosing diseases, such as sensors for atrial fib, arrhythmia, and hypoxia

Sensors that provide active feedback for controlling therapeutic medical devices

Example Products

Omron Wellness; HealthKit

Actigraph products; BIOPAC products; ResearchKit

Philips HealthSuite iRhythm atrial fibrillation sensors; Omron hypertension screening

Medtronic insulin pump systems & neurostimulators

FDA Regulated

No Typically not Yes Yes Yes – very highly

Page 9: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

Moving from consumer to medical wearables requires partnerships… but these two markets tend to clash

VALENCELL CONFIDENTIAL INFORMATION, PATENTS GRANTED & PENDING

Consumer fitness wearables• Crowdfunded + light VC• Glam marketing• Accuracy not a top priority• Loose on validation• Roman personality• Looks for ways to avoid FDA• 2-year timelines

Medical wearables• Heavily venture-backed• Conservative B2B marketing• Accuracy is critical• Heavy on validation• Greek personality• FDA approval is critical to success• 7+ year timelines

Page 10: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

FDA regulation is not the bottleneck with new medical wearables… Use case validation is the key obstacle

Prototyping(~2 - 5 weeks)

Use Case Validation(~year)

Feasibility Testing(~1 - 2 weeks)

Accuracy Validation

UX Validation

Independent Clinical Validation

FDA Approval(510K)

Page 11: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

Success in the medical wearables market will require both an understanding of the consumer market and clinical validation

VALENCELL CONFIDENTIAL INFORMATION, PATENTS GRANTED & PENDING

Page 12: Wearable technology innovation in healthcare and medical devices

©2016 Valencell. Inc

Key take-aways…

VALENCELL CONFIDENTIAL INFORMATION, PATENTS GRANTED & PENDING

• Mobile fitness technology has accelerated to the point where it is accurate enough for at least some medical purposes

• In some ways mobile fitness technology is actually outpacing medical technology

• With lower costs, better form-factors, and new features, advanced mobile fitness technology is now enabling ambulatory mobile healthcare, with a focus in prevention, screening, and disease management

• One point of friction is merging the rather chaotic exploration and rapid innovation of fitness wearables with the methodical discipline of clinical validation

• Companies that can apply medical-style validation to these innovative wearable sensor technologies are best-poised to find success in the marketplace

Page 13: Wearable technology innovation in healthcare and medical devices

Thank You!